Status: current, Primitive. Date: 31-Jul 2020. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3897066010 | Ubrogepant (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3897067018 | Ubrogepant | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ubrogepant | Is a | Heterocyclic compound | true | Inferred relationship | Some | ||
| Ubrogepant | Has disposition | Calcitonin gene-related peptide receptor antagonist | true | Inferred relationship | Some | ||
| Ubrogepant | Is a | Calcitonin gene-related peptide receptor antagonist | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ubrogepant only product | Has active ingredient | True | Ubrogepant | Inferred relationship | Some | 1 |
| Ubrogepant-containing product in oral dose form | Has active ingredient | True | Ubrogepant | Inferred relationship | Some | 1 |
| Ubrogepant-containing product | Has active ingredient | True | Ubrogepant | Inferred relationship | Some | 1 |
| Ubrogepant only product in oral dose form | Has active ingredient | True | Ubrogepant | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR